Crossref
Beta-blockers in acute coronary syndrome: current evidence and clinical implications
Klinická farmakologie a farmacie · 30.10.2025 · 39 (3) · 141-144
DOI: 10.36290/far.2025.055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinická farmakologie a farmacie, erschienen am 30.10.2025. Verfasst von Anna Chaloupka. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chaloupka, A. (2025). Beta-blockers in acute coronary syndrome: current evidence and clinical implications. Klinická farmakologie a farmacie, 39(3), 141-144. https://doi.org/10.36290/far.2025.055
Vancouver
Chaloupka A. Beta-blockers in acute coronary syndrome: current evidence and clinical implications. Klinická farmakologie a farmacie. 2025;39(3):141-144. doi:10.36290/far.2025.055
BibTeX
@article{Chaloupka2025,
author = {Chaloupka, Anna},
title = {Beta-blockers in acute coronary syndrome: current evidence and clinical implications},
journal = {Klinická farmakologie a farmacie},
year = {2025},
volume = {39},
number = {3},
pages = {141--144},
doi = {10.36290/far.2025.055}
}
EUVIMED